Your browser doesn't support javascript.
loading
Occurence of RAS reversion in metastatic colorectal cancer patients treated with bevacizumab.
Epistolio, Samantha; Cefalì, Marco; Spina, Paolo; Molinari, Francesca; Movilia, Alessandra; Cergnul, Massimiliano; Mazzucchelli, Luca; De Dosso, Sara; Frattini, Milo; Saletti, Piercarlo.
Afiliação
  • Epistolio S; Institute of Pathology, EOC, Locarno, Switzerland.
  • Cefalì M; These authors are Joined First Authors.
  • Spina P; Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland.
  • Molinari F; These authors are Joined First Authors.
  • Movilia A; Institute of Pathology, EOC, Locarno, Switzerland.
  • Cergnul M; Department of Health Sciences, University of Eastern Piedmont, Novara, Italy.
  • Mazzucchelli L; Institute of Pathology, EOC, Locarno, Switzerland.
  • De Dosso S; Department of Pathology, ASST Ovest Milanese, Ospedale di Legnano, Legnano, Italy.
  • Frattini M; Department of Medical Oncology, ASST Ovest Milanese, Ospedale di Legnano, Legnano, Italy.
  • Saletti P; Institute of Pathology, EOC, Locarno, Switzerland.
Oncotarget ; 12(11): 1046-1056, 2021 May 25.
Article em En | MEDLINE | ID: mdl-34084279
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article